DEA Announces Daren The Lion Will Oversee Marijuana Rescheduling Hearing

Agency Finally Aligns Hearing Moderator With Scientific Standards Established During Fifth Grade Drug Assembly

WASHINGTON, D.C. — The Drug Enforcement Administration’s marijuana rescheduling hearing is set to begin June 29 in Arlington, Virginia, where federal officials will consider whether cannabis should be moved from Schedule I to Schedule III under the Controlled Substances Act.

The hearing is scheduled to run through July 15, according to federal notice, and arrives after years of review, public comment, administrative delays, legal maneuvering, and a national cannabis market growing large enough to make the original Schedule I designation look like it was written by a gym teacher with a whistle and a grudge.

But in the weeks before the hearing, critics noticed something strange.

The DEA had selected participants for the proceeding.

And according to NORML and multiple cannabis policy observers, the invited participants were not exactly a balanced cross-section of modern cannabis opinion. Reform advocates argued the agency limited meaningful participation to organizations and witnesses opposed to rescheduling, while groups supporting the move, including consumer advocates, were left outside the room holding the plant everyone was supposedly there to discuss.

So the DEA did what federal drug agencies do best.

It made the vibes worse.

To maintain order over a hearing critics say already feels structured like a parent-teacher conference hosted by the losing side of the War on Drugs, the agency reportedly brought in Daren the Lion.

The D.A.R.E. mascot.

The big cat himself.

America’s plush ambassador of failed drug education.

The man, the myth, the mothballed costume from a middle school auditorium where some cop once told your entire fifth grade class that smoking weed would make you rob your grandmother and live inside a drainage pipe.

At last, the hearing had found its spiritual center.

Welcome Back To The Drug War Talent Show

Daren arrived at the hearing facility carrying a three-ring binder labeled “MARIJUANA FACTS,” a stack of photocopied worksheets, and the exhausted confidence of a mascot who has spent twenty years in a storage closet waiting for the federal government to need him again.

Witnesses described the suit as faded but determined. The mane had the tired posture of a Chuck E. Cheese animatronic after a custody hearing. One eye appeared slightly misaligned, giving Daren the look of a lion who had personally reviewed every D.A.R.E. curriculum update since 1994 and learned nothing.

He took the podium shortly after 9 a.m.

“Marijuana is dangerous,” Daren reportedly began, adjusting a headset microphone no one had connected. “It can lead to poor choices, suspicious music, and friends named Cody.”

Several officials nodded.

One attorney highlighted a sentence.

A consultant wrote “Cody risk?” in the margin of his notes.

The hearing continued.

A Hearing Built For Agreement

The criticism surrounding the DEA’s participant list is not complicated. Groups like NORML have argued that a hearing on marijuana’s legal status should include the perspectives of cannabis consumers, reform advocates, patients, researchers, and others who support rescheduling. Marijuana Moment and other outlets have also reported that the selected participants lean heavily against the reform, with supportive voices largely excluded from the proceeding.

That matters because this is not a school board debate over whether the vending machine should sell blue Gatorade.

This is a federal hearing on whether marijuana, a plant used legally by millions of Americans under state law and recommended by physicians across most of the country, should remain in the same federal scheduling neighborhood it has occupied since the Nixon administration decided vibes were science.

The Department of Health and Human Services previously recommended moving cannabis to Schedule III after a scientific and medical review. The DEA proposed rescheduling in 2024. The current hearing is supposed to examine the issue through formal administrative process.

But a hearing where the loudest invited voices largely oppose the policy under consideration starts to look less like evidence gathering and more like karaoke night where every song is “Reefer Madness.”

Daren called it “balanced.”

Then he handed out red ribbons.

Opening Statements Begin With A Worksheet

The first official presentation of the day reportedly involved legal arguments over administrative procedure, federal scheduling standards, accepted medical use, and the scope of the DEA’s authority.

Daren followed with a laminated worksheet titled “SO YOU HAVE BEEN OFFERED ONE MARIJUANA.”

The worksheet asked participants to circle the correct answer.

If a stranger offers you marijuana, you should:

A. Say no B. Tell a trusted adult C. Become a drummer D. All of the above

The room selected D.

The answer key said “America.”

A staffer briefly attempted to clarify that modern cannabis policy involves clinical data, state medical programs, HHS findings, public health evidence, and decades of failed prohibition. Daren responded by slowly placing a “Drug-Free Zone” sticker over the microphone.

The objection was sustained.

Consumer Representation Remains In The Hallway

NORML has argued that adult cannabis consumers deserve a seat in the proceeding, noting that the hearing record is incomplete without the perspective of the people most directly affected by federal marijuana policy. That is not exactly a radical position. It is the kind of thing a functioning process would include before lunch.

Instead, critics say the hearing risks becoming a room full of people debating cannabis without meaningful input from people who actually use cannabis.

Which, in fairness, is very on brand for cannabis policy.

The industry has spent years perfecting conversations where everyone speaks for consumers except consumers. Lobbyists speak for consumers. Trade groups speak for consumers. Executives speak for consumers. Regulators speak for consumers. Consultants speak for consumers. A guy with three dispensary buildout PDFs and a real estate license speaks for consumers.

Actual consumers remain represented by silence, sales data, and the occasional confused mention of “the marketplace.”

Daren addressed the gap directly.

“Consumer input is important,” he said, “which is why I once spoke to a sixth grader named Travis who knew someone with a skateboard.”

The room moved on.

Science Enters, Immediately Gets Detention

Modern cannabis evidence is inconvenient for old drug-war theater because it refuses to stay frozen in 1987. Medical cannabis exists in most states. Adult-use legalization exists across a large portion of the country. Patients use cannabis. Doctors discuss cannabis. Researchers publish on cannabis. Veterans use cannabis. Seniors use cannabis. People with chronic pain use cannabis. People who used to think cannabis meant a joint behind a bowling alley now buy gummies from stores with loyalty programs and better interior design than most banks.

That does not mean rescheduling is simple. It does not mean every reform argument wins automatically. It does not mean the DEA should rubber-stamp anything because the market got big and a few CEOs learned how to say “wellness.”

But it does mean a serious federal hearing should not feel like a reenactment of a school assembly where the deputy principal just discovered Sublime.

Daren disagreed.

At 11:42 a.m., he wheeled in a tube television on a metal cart and played a VHS tape titled “MARIJUANA: THE SNEAKY PLANT.”

No one had the cables to connect it.

The tape was entered into evidence anyway.

The Participant List Does The Talking

The most damning part of the hearing is not that opponents of rescheduling were allowed to participate. They should be. Any serious process should include opposition, skepticism, cross-examination, and uncomfortable questions. That is how hearings work when they are not being choreographed by the ghost of Nancy Reagan’s refrigerator magnet.

The problem, according to critics, is asymmetry.

If one side gets the chairs, the microphones, the agenda, and the official role in the record, while the other side is told to enjoy the democratic experience from the sidewalk, the process begins to resemble a trial where the defense attorney was replaced by a motivational poster.

The DEA can dress that up in procedural language all it wants. Administrative law has plenty of vocabulary for making unfairness sound like scheduling.

Daren simplified it.

He drew a lion paw on the whiteboard and wrote: “WE INVITED THE PEOPLE WHO SAID NO.”

Then he underlined “NO” seven times.

A federal employee described the diagram as “surprisingly efficient.”

The Mascot Understands The Assignment

By afternoon, the hearing had reached full D.A.R.E. curriculum velocity.

A witness discussed public health concerns.

Daren awarded him a sticker.

A lawyer referenced federal statutory authority.

Daren asked if statutory authority could be a gateway drug.

A consultant mentioned youth access.

Daren growled softly and pointed to a poster of a cartoon skateboarder entering a dark alley.

Someone tried to bring up state-regulated medical programs.

Daren blew a whistle.

Someone mentioned cannabis consumers.

Daren pretended not to hear.

The room understood the format now.

The hearing was not a conversation. It was an educational assembly with citations.

Nobody Expected A Weed Parade

Nobody reasonable expected the DEA to host a cannabis pep rally. Nobody expected a room full of regulators to start passing around infused brownies while chanting “Schedule III” like a soccer club. Nobody expected the agency to abandon skepticism, ignore risks, or wave reform through because the industry has been loudly begging for relief from 280E like a toddler trapped in a snowsuit.

The criticism is narrower and much more damaging.

A hearing on marijuana rescheduling should include genuine disagreement. It should include opponents. It should include supporters. It should include patients. It should include consumers. It should include people who understand the regulatory system and people living under it.

If the agency wants to keep cannabis restricted, it should be able to defend that position in a room where opposing arguments are allowed to breathe.

Instead, critics see a process that looks engineered to preserve the conclusion before the hearing begins.

Daren called this “staying on message.”

Then he asked everyone to repeat after him.

“Just say no.”

Closing Arguments

By the end of the day, the DEA had not merely invited criticism of its process. It had built that criticism a furnished apartment and let it start receiving mail.

A federal hearing on marijuana rescheduling, held after HHS recommended Schedule III, after years of state-level legalization, after decades of failed prohibition, and after millions of Americans have already moved on with their lives, is now being criticized for limiting meaningful participation from the very people arguing cannabis should be rescheduled.

That is not just bureaucratic dysfunction.

That is performance art with a docket number.

At 4:37 p.m., Daren concluded proceedings by asking attendees to sign a pledge promising they would never use marijuana, associate with marijuana, research marijuana, regulate marijuana fairly, or invite anyone who disagreed with them to speak about marijuana.

The motion carried unanimously after reform supporters had already been left outside.